Status:
COMPLETED
In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers
Lead Sponsor:
University of Colorado, Denver
Conditions:
Pregnancy Related
COVID
Eligibility:
All Genders
18+ years
Brief Summary
The pregnancy related pro-thrombotic state, in addition to the COVID-19 associated hypercoagulability may have unknown consequences to the developing fetus. Hence, this proposal seeks to address this ...
Detailed Description
Hypercoagulability and increased risk for venous thromboembolism (VTE) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients are well documented in the growing body of lite...
Eligibility Criteria
Inclusion
- Pregnant females, 18 years and higher, with documented COVID-19 infection (antigen, PRC, or antibodies in a biologic sample) during gestation who received medical care at the University of Colorado Hospital (UCH) or Children's Hospital Colorado (CHCO)
- Neonates born to COVID-19 infected mothers
- Neonates ages 1-60 days of life with documented limb anomalies and intestinal atresias
Exclusion
- Mothers with a history of vasoactive drug usage during pregnancy
- Mothers taking known teratogens during pregnancy
Key Trial Info
Start Date :
August 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT04431869
Start Date
August 18 2020
End Date
September 1 2021
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045